Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19

NCT07157007 is registered in ClinicalTrials.gov with Traws Pharma, Inc. as lead sponsor.

NCT NCT07157007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07157007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19
Lead sponsor
Traws Pharma, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
September 16, 2025
Completion date
March 31, 2026
Enrollment
90 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19